Novo Nordisk Slashes Weight-Loss Drug Wegovy's Prices as Competition Heats Up
8 Articles
8 Articles
Novo Nordisk slashes weight-loss drug Wegovy's prices as competition heats up
The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it loses patent exclusivity in March. Once the drug loses patent, top Indian generic drugmakers are poised to enter the market with lower-priced versions.
Novo Nordisk Slashes Wegovy Prices in India Amid Fierce Market Competition
Novo Nordisk Slashes Wegovy Prices in India Amid Fierce Market Competition Novo Nordisk, the Danish pharmaceutical giant, has announced a significant price reduction for its popular weight-loss medication, Wegovy, in the Indian market. The drug's cost has been slashed by up to 33%, a strategic move to bolster its presence in a rapidly expanding market for obesity treatments.Both Novo Nordisk and U.S.-based Eli Lilly are vying for dominance in th…
37% Slashed! Obesity Treatment In India Will Now Be Cheaper, Here’s How?
New Delhi: In a decisive move to widen access to obesity care, Danish pharmaceutical major Novo Nordisk has announced a 37 percent reduction in the Indian pricing of its once-weekly injectable medicine, Wegovy, targeting chronic weight management. Launched in India in June 2025, Wegovy is now available at significantly lower monthly rates across all its dose strengths. The lowest dose (0.25 mg) will now retail at Rs 10,850 per monthly pack (down…
Novo Nordisk India reduces Wegovy prices by 37% to expand access for people
Novo Nordisk India has announced a 37 per cent price reduction for all strengths of Wegovy. The company stated that this move is intended to make the obesity medication more accessible to a larger section of people living with overweight and obesity in India. Following the revision, the starting dose of Wegovy (0.25 mg) will now be available at an effective weekly price of INR 2,712, down from INR 4,336. Wegovy was launched pan-India in June 202…
Novo Nordisk (NVO) Slashes Wegovy Price in India Up to 37% as Board Vote Nears; U.S. Access Deal Sets 2026 Shift — Nov. 11, 2025
Meta description (160 chars): Novo Nordisk cuts Wegovy prices in India up to 37% and faces a pivotal board vote this week, as a U.S. pricing/access deal looms for 2026. Date: November 11, 2025 Key takeaways India: Wegovy gets markedly cheaper — and it’s about more than price Novo Nordisk cut Wegovy’s Indian list prices across the dose range, with the monthly 2.4 mg pack now at ₹16,400 (down from ₹24,389 at launch) and the 0.25 mg starter at ₹10,…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




